by Cort Johnson | Feb 21, 2025 | Drugs , Homepage , Low Dose Naltrexone , Nalmafine , Rapamycin , Treatment , Vagus nerve stimulation
Nalmefene may work better than low-dose naltrexone in ME/CFS, fibromyalgia, and long COVID, plus LDN and Rapamycin may help with osteoporosis.
by Cort Johnson | Feb 1, 2025 | Autophagy , Bateman , Energy Production , Homepage , Inflammation , Kaufman , Peterson , Rapamycin , Treatment
A successful rapamycin clinical trial in chronic fatigue syndrome (ME/CFS) leads to more studies and perhaps FDA approval
by Cort Johnson | Jul 5, 2024 | Autophagy , Epigenetics , Fecal Transplants , Genetics , Gut , Gut , Homepage , HPA axis , Immune , Inflammation , IVIG , long COVID , Longevity , Metabolism , Metformin , Microbiome , Neuroinflammation , Rapamycin , Research , T-cells , Treatment
Researchers propose that long COVID and chronic fatigue syndrome (ME/CFS) cause accelerated aging and that longevity treatments will help.
by Cort Johnson | Apr 22, 2024 | Cervical Stenosis , Connective Tissues , Craniocervical Instability , Ehlers Danlos Syndrome , Fibromyalgia , Homepage , Intracranial Hypertension , Kaufman , long COVID , Mast cell activation syndrome , Mast cell activation syndrome , Muscles , Neuroinflammation , Rapamycin , Rowe , Ruhoy , Small Fiber Neuropathy , Spine
Drs. Ruhoy and Kaufman discuss the many roles connective tissue problems may play in chronic fatigue syndrome (ME/CFS), fibromyalgia and long COVID and how they treat them.
by Cort Johnson | Sep 16, 2022 | Autophagy , Energy Production , Inflammation , Neuroinflammation , Rapamycin , Research
Impaired mitochondrial cleanup processes (autophagy) in chronic fatigue syndrome may be hampering the ability of their cells to produce energy.